Wyndly vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
Telehealth allergy immunotherapy with at-home test kits and sublingual drops by mail; making multi-year desensitization treatment accessible without clinic visits.
About
Wyndly is a digital telehealth platform providing allergy immunotherapy treatment by mail, enabling patients to begin long-term allergy desensitization without the time commitment of in-office allergy shot clinics. Founded in 2020 and headquartered in Wilmington, Delaware, Wyndly's service involves an at-home allergy test kit, virtual consultation with an allergist, and custom-formulated sublingual immunotherapy drops delivered to the patient's home — making a years-long treatment process dramatically more convenient than traditional allergy shot protocols.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.